NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ilya M. RachmanCEO and Chairman2025-09-172,500$2.02
$5.05kBuy
Gabriel S. MorrisCFO2025-09-162,600$1.97
$5.12kBuy
Gabriel S. MorrisCFO2025-06-182,225$2.28
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-06-182,178$2.30
$5.00kBuy
Jason HsuDirector2024-12-2340,000$2.19
$87.68kBuy
Jason HsuDirector2024-12-207,700$2.17
$16.68kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky9.65%3,241,076$18.02MInsider
Ilya M. Rachman3.40%1,140,937$6.34MInsider
Carey Ng3.11%1,045,221$5.81MInsider
Jason Hsu2.81%943,000$5.24MInsider
Nancy T. Chang2.74%918,880$5.11MInsider
Vladimir P. Torchilin2.70%905,200$5.03MInsider
Sean Senn2.68%899,800$5.00MInsider
Bleichroeder LP2.53%850,000$4.73MInstitution
Vanguard Group Inc2.17%730,162$4.06MInstitution
Gabriel S. Morris0.94%314,800$1.75MInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX8.24%28.86%Net BuyingNet Buying
SABS35.08%64.92%Net BuyingNet Buying
CBIO13.64%86.36%
RANI3.32%33.62%Net SellingNet Selling
CRBP40.84%59.16%Net SellingNet Buying

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 8.24% institutional shareholders, 28.86% IMMIX Biopharma insiders, and 62.90% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 9.65% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $18.02M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.